These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome. Wang S; Umrath F; Cen W; Salgado AJ; Reinert S; Alexander D Cells; 2022 Mar; 11(6):. PubMed ID: 35326438 [TBL] [Abstract][Full Text] [Related]
23. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. Estrada R; Li N; Sarojini H; An J; Lee MJ; Wang E J Cell Physiol; 2009 Jun; 219(3):563-71. PubMed ID: 19170074 [TBL] [Abstract][Full Text] [Related]
24. Ascorbic acid and IFNγ preconditioning enhance the potency of human mesenchymal stem cells to ameliorate LPS induced cytokine storm. Sanap A; Kheur S; Kharat A; Bhonde R Int Immunopharmacol; 2023 Sep; 122():110643. PubMed ID: 37453155 [TBL] [Abstract][Full Text] [Related]
33. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. Cunningham CJ; Redondo-Castro E; Allan SM J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965 [TBL] [Abstract][Full Text] [Related]
34. Materials Stiffness-Dependent Redox Metabolic Reprogramming of Mesenchymal Stem Cells for Secretome-Based Therapeutic Angiogenesis. Yang H; Cheam NMJ; Cao H; Lee MKH; Sze SK; Tan NS; Tay CY Adv Healthc Mater; 2019 Oct; 8(20):e1900929. PubMed ID: 31532923 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866 [TBL] [Abstract][Full Text] [Related]